Old Web
English
Sign In
Acemap
>
authorDetail
>
Ana Sebrango
Ana Sebrango
Delayed toxicity
Refractory
Rituximab
Response rate (survey)
Thrombotic thrombocytopenic purpura
2
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study
2010
Transfusion and Apheresis Science
Javier de la Rubia
Federico Moscardó
María J Gómez
Ramon Guardia
Pilar Rodríguez
Ana Sebrango
Concepción Zamora
Guillermo Deben
Rosa Goterris
Rafaela López
Francisco Peña
Misericordia Pujol
Antonio Vidaller
Julio del Río-Garma
Miguel A. Sanz
Show All
Source
Cite
Save
Citations (52)
Efficacy and Safety of Rituximab in Adult Patients with Idiopathic Relapsed or Refractory Thrombotic Thrombocytopenic Purpura (TTP). Results of a Spanish Multicenter Study.
2008
Blood
Javi er de la Rubia
Federico Moscardó
María J Gómez
Ramon Guardia
Pilar Rodríguez
Ana Sebrango
Concha Zamora
Guillermo Deben
Rosa Goterri
Rafaela López
Francisco Peña
Micola Pujol
Show All
Source
Cite
Save
Citations (0)
1